结核病延迟和结核病治疗结果在HIV-TB同时感染的患者之间的关联:基于多级倾向得分方法的研究
Rujun Liao1,2, Lin Hu3, Jie Yu3
1Center of Infectious Diseases, Research Center of Clinical Epidemiology and Evidence-Based Medicine, Innovation Insititute for Integration of Medicine and Engineering, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
BMC infectious diseases
|April 30, 2024
概括
在HIV-TB同时感染的患者中,结核病 (TB) 诊断和治疗的延迟显著增加了治疗不良结果的风险. 改善医疗保健系统以加快诊断和治疗对于更好的患者结果至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 艾滋病毒 - 结核病 (HIV-TB) 联合感染是一个重大的全球卫生挑战.
- 结核病护理的延迟,包括患者,诊断和治疗阶段,与较差的抗结核病治疗 (ATT) 结果有关.
- 区域因素可以影响ATT的结果,但很少有研究充分解决了个别和区域的混变量.
研究的目的:
- 评估中国梁山县HIV-TB同时感染患者的结核病延迟和治疗结果之间的关联.
- 采用因果推理框架,考虑个人和区域的混因素.
主要方法:
- 分析了2068名在梁山县同时感染艾滋病毒和结核病的患者 (2019-2022) 的数据.
- 使用因果定向非循环图 (DAG) 来识别和控制混变量.
- 应用多层倾向得分和反向概率权重 (IPW) 来减轻偏差.
主要成果:
- 艾滋病毒-结核病同时感染患者的ATT成功率为91.2%.
- 总延迟 (OR=1.411),诊断延迟 (OR=1.778),治疗延迟 (OR=1.749) 和卫生系统延迟 (OR=1.480) 是不利的ATT结果的重要风险因素.
- 敏感性分析证实了这些发现的可靠性.
结论:
- 对被诊断为HIV-TB同时感染患者的早期治疗优先考虑,对于梁山县的预防和控制政策至关重要.
- 需要紧急改善医疗保健系统,以减少艾滋病毒-结核病同时感染患者的诊断和治疗延迟.
相关概念视频
Pulmonary Tuberculosis I
241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
Pulmonary Tuberculosis V
178
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
178
Pulmonary Tuberculosis IV
140
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
140
Pulmonary Tuberculosis III
324
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
324
Pulmonary Tuberculosis II
226
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
226
Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178


